
Icon has acquired US clinical trial specialists Aptiv Solutions for $143.5 million as it looks to expand its footprint in …
Contract research organisation Quintiles Transnational has pulled back from plans to seek $2.4 billion in financing, saying that conditions in …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

